Summary
The U.S. Food and Drug Administration is soliciting quotations for Maxwell RSC 48 DNA Extraction Systems or equal, including delivery, installation, on-site training, warranty support, and related services for FDA laboratory facilities. The acquisition is a full-and-open commercial RFQ and will establish a five-year Blanket Purchase Agreement, with award based on Lowest Price Technically Acceptable evaluation of technical acceptability, past performance, and price. Quotations are due July 31, 2026, at 10:00 a.m. Eastern Time, and initial deliveries will support FDA laboratories in Arkansas, Georgia, California, Colorado, Washington, and New York.